What is NDC 53747-352?

53747-352 is the product NDC for Doxazosin Mesylate, Doxazosin mesylate 2 mg/1 tablet, listed with the FDA by Unichem Laboratories Limited, India. It has 3 package NDCs, shown above in 10- and 11-digit form.

Unichem Laboratories Limited, India, NDC labeler code 53747. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxazosin Mesylate?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxazosin Mesylate NDC 53747-352 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)53747-352Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53747-0352Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
53747-352-01	5374703520153747035201	100 TABLET in 1 BOTTLE (53747-352-01)Marketed from Mar 15, 2024
53747-352-10	5374703521053747035210	1000 TABLET in 1 BOTTLE (53747-352-10)Marketed from Mar 15, 2024
53747-352-13	5374703521353747035213	30 TABLET in 1 BOTTLE (53747-352-13)Marketed from Mar 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxazosin Mesylate
Generic name (nonproprietary): doxazosin mesylate
Active ingredients: Doxazosin mesylate — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Unichem Laboratories Limited, IndiaNDC labeler code 53747
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212329
Marketing start: Jan 10, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 53747-352_761d3af7-ac26-462c-a5a0-0435f782bd62SPL ID 761d3af7-ac26-462c-a5a0-0435f782bd62
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453747035201 followed by a unit qualifier and the quantity

Package 53747-0352-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 53747-352

What is NDC 53747-352?: 53747-352 is the product NDC for Doxazosin Mesylate, Doxazosin mesylate 2 mg/1 tablet, listed with the FDA by Unichem Laboratories Limited, India. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxazosin Mesylate.
What is the active ingredient?: Doxazosin mesylate.
Who is the labeler?: Unichem Laboratories Limited, India, NDC labeler code 53747. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin Mesylate?: 13 other product NDCs are listed under this name. See all Doxazosin Mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin Mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1391	59762-1391-07
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1390	59762-1390-07
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-965	71610-0965-5371610-0965-6071610-0965-70
Doxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1388	59762-1388-07
Doxazosin mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1389	—
Doxazosin Mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-351	29300-0351-0129300-0351-1029300-0351-13
Doxazosin Mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-352	29300-0352-0129300-0352-1029300-0352-13
Doxazosin Mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-353	29300-0353-0129300-0353-1029300-0353-13
Doxazosin Mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-354	29300-0354-0129300-0354-1029300-0354-13
Doxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Chartwell RX, LLC	62135-051	62135-0051-90

All 14 Doxazosin Mesylate NDCs

Other NDCs under ANDA 212329

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212329
Product	Strength	Form · route	Labeler	Product NDC
Doxazosin Mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-351
Doxazosin Mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-352
Doxazosin Mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-353
Doxazosin Mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-354